The purpose of this research study is to: 1) evaluate how well IMR-687 is tolerated in subjects with β-thalassemia and how safe it is, 2) measure the amount of IMR-687 in your blood and 3) evaluate what the drug does to the red blood cells and other blood markers associated with your disease.
Drug IMR-687 is not FDA approved for use.
This study will look at two different dose levels of IMR-687 and compare how these work to a placebo, which is a substance that looks like an active drug but has no active drug in it.
This study is a randomized trial which means that participants will be randomly assigned to one of the study drug doses (high dose or low dose of IMR-687, or placebo).
Study Identifier: 844255
Contact the research team to learn more about this study.